Birger Sorensen
Oslo, 0349, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.
Journal: QRB discovery
Published: May 18, 2020
Correlation of Antibody Responses to a Peptide Antigen gp120-C5501-512/gp41732-744 with HIV Disease Progression.
Journal: AIDS research and human retroviruses
Published: January 05, 2017
Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial.
Journal: PloS one
Published: July 28, 2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Infectious diseases
Published: February 15, 2014
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: February 21, 2012
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
Journal: Scandinavian journal of infectious diseases
Published: February 21, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026